Differential Effects of Oleoyl Serine and HU-910 on Anxiety and Depression in WKY Rats
| Journal | International journal of molecular sciences |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
The role of the endocannabinoid system (ECS) in the development of depression and anxiety is being actively studied, with evidence suggesting that elevation of ECS signaling can have anxiolytic and antidepressant properties. The current study explored the therapeutic potential of Oleoyl Serine (OS), an endocannabinoid-like lipid, and HU-910, a synthetic selective Cannabinoid type 2 (CB2) receptors agonist, in depression and anxiety, using both sexes of the depressive-like genetic model: Wistar Kyoto (WKY) rats. The aim was to investigate behavioral and molecular mechanisms associated with acute and sub-chronic intraperitoneal administration of these compounds. We showed that, in females, acutely administered OS yielded antidepressant-like and anxiolytic-like effects in the Forced Swim Test (FST) and Open Field Test (OFT), respectively. In males, OS yielded acute and sub-chronic anxiolytic-like effects. HU-910 yielded an acute anxiolytic-like effect in females and an acute antidepressan
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What are oleoyl serine and HU-910?
Oleoyl serine (OS) is an endocannabinoid-like lipid, and HU-910 is a synthetic compound that acts as a selective agonist of cannabinoid type 2 (CB2) receptors. This study explored the therapeutic potential of both compounds for depression and anxiety in a genetic rat model of depressive-like behavior.
Why are endocannabinoid compounds being studied for depression and anxiety?
The role of the endocannabinoid system in the development of depression and anxiety is being actively studied. According to the article, evidence suggests that raising endocannabinoid system signaling can have anxiolytic (anxiety-reducing) and antidepressant properties, which is the rationale for testing compounds that act on this system.
How was this oleoyl serine and HU-910 study designed?
The researchers used Wistar Kyoto (WKY) rats of both sexes, a genetic model of depressive-like behavior. The compounds were given by intraperitoneal administration, both acutely and sub-chronically, and the aim was to investigate the behavioral and molecular mechanisms associated with these treatments.
How did oleoyl serine and HU-910 affect female and male rats?
In females, acutely administered oleoyl serine produced antidepressant-like effects in the Forced Swim Test and anxiolytic-like effects in the Open Field Test. In males, oleoyl serine produced anxiolytic-like effects with both acute and sub-chronic dosing. HU-910 produced an acute anxiolytic-like effect in females. These are behavioral findings in rats, not in people.
